Skip to main content
Clinical and Translational Allergy logoLink to Clinical and Translational Allergy
. 2020 Nov 9;10:48. doi: 10.1186/s13601-020-00356-5

Retraction Note to: Partially hydrolysed, prebiotic supplemented whey formula for the prevention of allergic manifestations in high risk infants: a multicentre double-blind randomised controlled trial

Robert Boyle 1,, Nick Brown 2, Wen Chin Chiang 3, Chua Mei Chien 3, Michael Gold 4, Jonathan Hourihane 5, Jane Peake 6, Patrick Quinn 4, Raj Rao 7, Peter Smith 8, Mimi Tang 9, John Ziegler 10, John Warner 1
PMCID: PMC7653747  PMID: 33524077

Retraction Note to: Clin Transl Allergy (2015) 5(Suppl3):P30 10.1186/2045-7022-5-S3-P30

The authors have retracted this poster abstract [1] because of concerns regarding the validity of the post-hoc analysis presented here. An independent statistical analysis has found that the post-hoc analysis used a very small sample, which means the results are not generalizable to the original sample included in the trial. Conclusions based on results from this restricted sample are therefore unreliable. The effects seen are unlikely to be due to the active intervention and instead might be due to residual confounding related to age of weaning.

All authors agree to this retraction.

Footnotes

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Reference

  • 1.Boyle R, Brown N, Chiang WC, Chien CM, Gold M, Hourihane J, Peake J, Quinn P, Rao R, Smith P, Tang M, Ziegler J, Warner J, et al. Partially hydrolysed, prebiotic supplemented whey formula for the prevention of allergic manifestations in high risk infants: a multicentre double-blind randomised controlled trial. Clinical and Translational Allergy. 2015;5(3):P30. doi: 10.1186/2045-7022-5-S3-P30. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Clinical and Translational Allergy are provided here courtesy of Wiley

RESOURCES